# Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC（AK104-IIT-13）

> **NCT05794750** · PHASE2 · NOT_YET_RECRUITING · sponsor: **JIN JING** · enrollment: 50 (estimated)

## Conditions studied

- Locally Advanced Rectal Cancer

## Interventions

- **DRUG:** AK104 injection
- **PROCEDURE:** TME surgery
- **DRUG:** Capecitabine
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT05794750
- **Lead sponsor:** JIN JING
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-04-24
- **Primary completion:** 2027-04-24
- **Final completion:** 2027-04-24
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05794750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05794750, "Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC（AK104-IIT-13）". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05794750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*